- Journalists Shed Light on Deadly Hantavirus Outbreak and a Crisis in the Nation’s ERs
- Is the horizon still bright for orthodontists?
- The Make America Healthy Again Movement Comes for Hospital Food
- What’s driving physicians to early retirement
- Why Tenet’s CEO says ASCs keep choosing USPI
- 12 recent hospital, health system president exits
- Hospitals embrace rapid opioid treatment in fentanyl era: Study
- Texas systems open 200-bed behavioral health center
- 32 health systems spending $5B on cancer care
- Sanford, North Memorial planned combination adds to Minnesota healthcare deal wave
- Lone Peak Dental Group acquires Arizona practice
- Inside Northwestern Medicine’s battle against surgeon burnout
- UT Austin launches Epic ahead of new academic medical center
- Ohio system names COO
- Buy, sell or fight: The new calculus of health system growth
- OpenAI’s growing healthcare footprint
- Tennessee optometrist pleads guilty to $6.9M Medicare fraud
- Why Cook County Health’s Medicaid coverage loss strategy is drawing attention
- Akron Children’s chosen for former Ohio college campus site
- Surgery Partners doubles down on orthopedics, robotics as total joint growth hits 14.6%
- The growing war over Anthem’s out-of-network penalty policy
- 3 PDS Health headlines to know in 1 week
- Remarks at the Conference on Financial Market Regulation
- Could ASCs help cardiology move past its ‘breaking point’?
- 3 programs expanding the anesthesia workforce in 2026
- Dad Jokes: Remarks at the 13th Annual Conference on Financial Markets Regulation
- UVM Health targets $300M in cuts, outpatient overhaul amid $280M deficit
- Maine behavioral health provider cites industry pressures in merger
- Dentists opening practices in 1 month
- The Aspen Group names new chief commercial officer
- RFK Jr. Launches Plan To Curb Antidepressant 'Overprescription'
- Georgia mental health provider adds after-hours outpatient program
- AI-augmented behavioral health provider Theris launches out of stealth
- 5 data breaches, settlements impacting cardiology
- Maine hospital adds stroke prevention, cardiac imaging services
- As new tech, AI sweeps the marketing world, Eversana Intouch’s new CEO is ‘comfortable in the gray’
- Sanford Health unveils deal to integrate Minnesota-area North Memorial Health, invest $600M
- Trump plans to fire FDA chief Marty Makary: report
- Trump plans to fire FDA chief Marty Makary: report
- Oregon governor signs behavioral health workforce expansion bills amid shortage
- Remarks at the Special Competitive Studies Project AI+ Expo
- Lawmakers, former FDA leaders and more rally behind mifepristone as Supreme Court weighs telemedicine access to abortion pill
- 5 DSOs making headlines
- Plant-Based Foods May Help Lower Risk of High Blood Pressure
- The ACA exchanges dominated Q1 earnings calls. Here's what payer, health system execs had to say
- Targeted Protein Degradation and Novel Modalities: Getting on the Frontline
- Gilead cranks up Yeztugo first-year sales forecast to $1B on 'unprecedented launch trajectory'
- Capricor Therapeutics files breach-of-contract lawsuit against US partner NS Pharma
- Op-ed: It's time to make more strategic bets on AI in healthcare
- Daiichi Sankyo takes $610M profit hit linked to ADC manufacturing overbuild
- Super Shoes Might Increase Risk Of Running Injuries, Study Says
- TV, Movies Offer Flawed Depictions Of Autism, Add To Delayed Diagnosis, Study Says
- Opioid OD Survivors Have Triple Rate Of Repeat Overdoses Than Previously Estimated
- Revisiting Pharma’s tariff reality
- A New Medicare Option For Weight Loss Drugs: What Older Americans Should Know
- Exposure Therapy Can Successfully Ease Peanut Allergies
- Listen: A Federal Agency Is After Workers’ Health Data, and Critics Are Alarmed
- In California Governor Race, Single-Payer Is a Litmus Test. There’s Still No Way To Pay for It.
- AbbVie’s Skyrizi beats out J&J’s Tremfya in April drug ad spending leaderboard
- Johnson & Johnson launches ‘Generation Fine’ depression project
- Pre-launch efforts linked to lasting drug awareness edge: report
- GSK tees up a Modern Family for meningitis messaging
- NYC invests $12M in overdose recovery workforce
- Aspen Dental to pay $2M to settle allegations of violating corporate dentistry laws
- Texas dental practice relocates into 6K-square-foot facility
- Medit launches global orthodontics division, acquires California training institute
- Pennsylvania enacts dental faculty bill
- Cruise Ship Hantavirus Outbreak Kills 3 as WHO Says Risk Is Low
- How policy, reimbursement incentives, could help healthcare address its climate footprint
- Remarks at the 13th Annual Conference on Financial Market Regulation
- 5 best practices for financially integrating behavioral health
- Fierce Pharma Asia—Summit’s surprise interim trial miss; UCB’s $2B Candid buy; J&J’s CAR-T cuts
- Amazon Pharmacy to offer home delivery for Novo Nordisk's Ozempic pill
- New York expands behavioral health data access in EHRs
- Staffing firm Cross Country Healthcare to be acquired by Knox Lane for $437M
- New Hampshire to receive $29.5M in Purdue opioid settlement
- Behavioral health leaders counter HHS ‘overprescribing’ narrative
- Clover Health's MA membership grows 51% year-over-year
- New Study Suggests The Brain Can Continue Learning While In An Unconscious State
- Health Tech Weekly Rundown: Tether rolls out medical AI for phones, wearables; Medaptus launches operational ‘command center’
- Pennsylvania sues Character.ai over AI chatbot allegedly presenting itself as licensed medical professional
- Angelini finds Catalyst for its US growth ambitions with $4.1B buyout
- FDA to reconsider shock rejection of cell therapy Ebvallo. Could uniQure be next?
- Every 1,000 Steps After Surgery Cuts Complication Risk, Study Finds
- Bullying and Politics Fuel Suicide Risk for LGBTQ+ Teens and Young Adults, Survey Finds
- Head Impacts May Disrupt Gut Health Even Without Concussion
- Class of Migraine Drug, CGRP Inhibitors, Has Added Benefit: Reduced Glaucoma Risk
- States Eye Aid to Prop Up Distressed Hospitals Amid Federal Medicaid Cuts
- That Discount at the Pharmacy Counter May Pack Hidden Costs
- Trump Promised Cheaper Drugs. Some Prices Dropped. Many Others Shot Up.
- Hims & Hers debuts its first AI care agent to interpret biomarker lab results
- Alnylam rebuked by FDA over efficacy claims on Amvuttra website
- Insulet CEO details ‘Scrubs’ device promotion win as it boosts awareness, education drive
- Oscar Health's profit hits $679M, membership rises in Q1
- Joint Commission, NACHC partner on training, new accreditation for community health centers
- Ardent Health touts outpatient growth, checked labor spend during hectic Q1
- FDA Authorizes Fruit-Flavored Vapes for Adults
- Sanofi asks to pull Tzield bid from FDA's controversial CNPV program: report
- FDA rolls out 1-day assessment pilot in bid to refocus inspection resources
- Nearly 8 in 10 employers say GLP-1 coverage drives up benefit costs: Business Group on Health
- Edibles + Alcohol Combo Poses Driving Risks Missed by Sobriety Tests
- Leapfrog Group's latest safety grades have far fewer low scores since removal of non-participating hospitals
- VR Training Helps Autistic People Navigate Police Encounters
- Novo CEO cites pricing 'sweet spot' as Wegovy pill debuts with $355M quarter
- Weight Loss Surgeries Fall More Than 20% As Patients Turn To GLP-1 Meds, Experts Say
- FDA blocks publication of COVID, shingles vaccine safety studies: NYT
- Bayer diagnoses how to build trust in cell and gene therapies
- Amwell boasts higher than expected renewals, retention despite Q1 revenue decline
- First Psych Ward Stay Signals Long-Term Mental Health Struggles For Nearly All Patients
- Why Melatonin Shouldn't Be A Bedtime Go-To For Kids
- Children Living Near Gas Stations Have Higher Cancer Risk, Study Finds
- The timing is right for psychedelics manufacturer Optimi Health's IPO
- HHS' Healthy Food Agenda Puts Hospitals On Notice About Patients' Meals
- A New Medicare Option for Weight Loss Drugs: What Older Americans Should Know
- Trump’s Drug Strategy Aims To Bolster Addiction Services — Despite Gutting of Government Support
- Inside the gaps in fertility and surrogacy systems
- CVS execs say company on track to meet MA margin goals by 2028
- Facilitating Access to Trump Accounts
- Fixing Failures to Communicate
- Hinge Health lifts 2026 outlook after strong Q1 as it expands to new conditions
- For nonprofit hospitals, pricey management consultants haven't yielded better performances: study
- Supreme Court Issues Stay, Keeping Abortion Pill Mifepristone Available by Mail For Now
- Statement on Proposing Release for Semiannual Reporting
- Quarterly Questions: Statement on the Proposed Amendments to Allow Semiannual Reporting
- Statement on Proposing Semiannual Reporting
- Wellstar partners with BD to implement AI-driven medication management system
- Listen to the Latest ‘KFF Health News Minute’
- Newer Migraine Drugs Reduce Headache Days With Fewer Side Effects
- New Drug Combo Effective Against Treatment-Resistant IBD, Trials Show
- New Warning Labels Might Help People Cut Back On Drinking
- Ozempic Can Curb Cravings in Alcohol Use Disorder, Landmark Trial Finds
- US on the Brink of Losing Measles-free Status, Study Warns
- Delays in Visa Program Threaten Doctor Placements in Underserved Areas
- States Eye Aid To Prop Up Distressed Hospitals Amid Federal Medicaid Cuts
- Supreme Court Puts Brakes on Abortion Pill Restrictions
- FDA Green Lights Expanded Access to Pancreatic Cancer Drug, Daraxonrasib
- Online Misinformation Adding To Americans' Skin Cancer Risk, Survey Finds
- Medtronic’s Updated Mitral Valve, Mosaic Neo, Gets FDA approval
- Medtronic’s Updated Mitral Valve, Mosaic Neo, Gets FDA approval
- Social Media Videos, Easy Access Raise Risk of Teen Inhalant Use
- Staff Statement Regarding Pooled Employer Plans
- Sonire Therapeutics Initiates First U.S. Clinical Study of Ultrasound-Guided HIFU Therapy for Pancreatic Cancer
- Sonire Therapeutics Initiates First U.S. Clinical Study of Ultrasound-Guided HIFU Therapy for Pancreatic Cancer
- Edwards Lifesciences Shares Ten-Year Pivotal Data Supporting Long-Term Durability of Resilia Tissue
- Edwards Lifesciences Shares Ten-Year Pivotal Data Supporting Long-Term Durability of Resilia Tissue
- 'Fitspirational' Posts Can Be More Harmful Than Motivational, Review Concludes
- Parents’ Stress Tied to Children’s Mental Health, New Survey Finds
- Surgeon Multitasking Increases Death Risk Of Organ Transplantees
- When Natural Disasters Strike, Another Crisis Hits Those Recovering From Opioid Addiction
- FDA Recalls Several Ghirardelli Powdered Beverages Over Potential Contamination
Most of Michigan isn't so sure what's wrong with corporate welfare, especially when their town gets a "free" grant.
But we should ask ourselves: how cozy are the Swamp and Corporate Welfare - cozy, identical, or just co-dependent?
Here's a Michigan Primer to get you started, courtesy The Midwesterner News.
@ColinJoyce
Rep. DeBoyer: MEDC hiding SOAR corporate welfare failures by renegotiating contracts
Government investment handout thus far expected to total $10.2 billion
After spending nearly $3 billion over the last dozen years, the Michigan Economic Development Corporation is working to claw back about $21.9 million in failed corporate welfare deals.
So far, the agency headed by appointees of Gov. Gretchen Whitmer has recovered roughly $18.3 million, though the MEDC is shielding other failures by renegotiating some of its biggest taxpayer-funded incentives when companies fail to meet hiring and investment metrics, according to The Detroit News.
“I think it’s important to recognize, instead of acknowledging failures, they just renegotiate the contract on what they’re able to accomplish,” state Rep. Jay DeBoyer, the Clay Twp. Republican chair of the House Oversight Committee, told the news site. “Imagine doing that with your kid when it comes to doing their chores.”
The data follows a request from DeBoyer earlier this month as his committee works to assess the performance of the state’s largest business incentive programs, which Whitmer and select lawmakers have leveraged to court big business, much of it centered on the electric vehicle industry.
The review is part of a broader effort by House Republicans to shift funding from the taxpayer-funded corporate subsidies to fulfill Whitmer’s campaign promise to “fix the damn roads.”
Records show the Michigan Business Development Program, launched in 2012, has provided 271 businesses a total of $289.8 million in incentives for an expected investment of $10.2 billion.
Sixty-two or 23% of those deals were canceled or are in repayment because grantees did not fulfill their requirements, while another 21 are in default or have declared bankruptcy. Sixty-seven, or about a quarter, were contracted last year, according to records reviewed by The News.
MEDC has identified $21.9 million in clawbacks for that program, and has collected $18.3 million so far, the MEDC told DeBoyer.
A separate Michigan Community Revitalization Program that also launched in 2012 has doled out another $365 million for 172 grants and loans to incentivize private investment in historic or brownfield sites, and the MEDC report does not detail if any are in default.
A third business incentive program created by lawmakers in 2021 known as the Strategic Outreach and Attraction Reserve committed another $2.8 billion to court massive investments in the EV and renewable energy industries. While both Ford and General Motors, the two biggest beneficiaries of SOAR funds, have scaled back their investments, Whitmer’s MEDC has not worked to claw back the funds, opting instead to renegotiate those contracts, corporation spokesman Otie McKinley told The News.
“There have been no clawback provisions triggered for SOAR projects to date,” McKinley said. “In some cases, awards have not yet been fully disbursed.”
“These latest developments underscore what I’ve been saying all along — projects like this require much stricter oversight,” said state Rep. Sarah Lightner, R-Springport. “We must have safeguards in place to protect taxpayers from financial risks and national security threats. If a project is tanking, or it turns out to have ties to a questionable company, we need the ability to claw back those funds and redirect them to better uses.”
Ford’s decision was followed by GM’s announcement in December it’s backing out of a joint venture with South Korea-based LG Energy Solution for a $2.5 billion Ultium Cells battery plant near Lansing that came with a $120 million SOAR grant.
MEDC officials ultimately cut Ford’s taxpayer cash from about $1.75 billion to between $384 and $409 million, depending on the number of jobs created, according to Bridge Michigan.
MEDC paid out GM’s SOAR grant in 2023, well before any jobs were created, and last week voted not to claw back the funding, opting instead to transfer the obligation to create 1,360 jobs to LG.
Other SOAR deals are also poised to flop, with CCP-linked Gotion, Inc. CEO Chuck Thelen announcing on Friday he halted the state permitting process to build the Gotion EV battery component plant in Mecosta County amid litigation over its fate.
Like GM and Ford, Gotion landed $715 million in taxpayer incentives from the SOAR program through secretly negotiated agreements with Whitmer’s MEDC and select lawmakers in 2022, before widespread opposition over the company’s ties to communist China derailed its plans.
The struggles at MEDC are nothing new.
A broader analysis of corporate incentive deals in Michigan from 2000 to 2020 found that out of a total of 123,060 new jobs promised, a mere 10,889 actually materialized, a success rate of just 9%.
“Only one in 11 of the announced jobs in these front page stories ever came to fruition,” according to Front Page Failures, released by the Mackinac Center for Public Policy in December 2024.
Another analysis of the first $1 billion in SOAR grant money spent found similar results, with Bridge Michigan identifying the creation of a total of 200 out of 12,000 promised jobs as of mid-June 2024.
MEDC officials argue the SOAR program hasn’t yet matured enough to effectively analyze whether it’s meeting its goal of attracting and retaining jobs in Michigan, but Boyer and his oversight committee aren’t buying it.
“The private sector measures their earnings matrix on a quarterly basis and you’re telling me the government can’t measure its matrix years down the road?” DeBoyer said. “That is messaging to conceal failures.”
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.













